Cyclodextrin Host–Guest Chemistry

The molecular architecture

Each cyclodextrin is a cyclic oligosaccharide of D-glucose units joined by α-1,4 glycosidic bonds — the same linkage found in starch, from which they are made. The chair-form glucoses tilt so the whole macrocycle adopts the shape of a hollow, slightly tapered truncated cone rather than a flat ring.

• The secondary hydroxyls (C2 and C3–OH) line the wider rim; the primary hydroxyls (C6–OH) line the narrower rim. Both rims are hydrophilic, keeping the molecule water-soluble.
• The interior is lined by C3–H, C5–H, and the glycosidic ether oxygens, giving it a relatively apolar, hydrophobic character — a pocket that resembles the inside of an organic solvent.

The three common natives are α (6 glucoses), β (7), and γ (8). Their cavity diameters increase from roughly 5 to 8 Å, which is precisely why the guest that fits best changes with ring size: α-CD grips small linear molecules, β-CD is a near-perfect socket for a benzene ring, and γ-CD can swallow steroids or even C₆₀ fullerene (as a 2:1 γ-CD:fullerene complex).

How binding works — the driving forces

Inclusion is a purely non-covalent event. In water, the empty cavity is filled by a few "activated" water molecules that cannot form their full complement of hydrogen bonds inside the apolar pocket — they are enthalpically frustrated. When a hydrophobic guest enters, it expels these high-energy waters back into bulk solvent, where they hydrogen-bond freely. This release of cavity water is the single most important contribution and is the classic hydrophobic effect.

Several forces add up:

• Hydrophobic effect / water release — the dominant thermodynamic driver, often entropy-favorable.
• Van der Waals and London dispersion contacts between the guest and the snug cavity wall — these reward a tight geometric fit ("lock and key" size matching).
• Hydrogen bonding between guest polar groups and the rim hydroxyls, and relief of ring strain in the macrocycle.

Because the interaction is reversible, complexation is an equilibrium: Host + Guest ⇄ Complex, with an association constant K_a. For a typical aromatic guest in β-CD, K_a is 100–10,000 M⁻¹, corresponding to a ΔG of roughly −12 to −25 kJ/mol — strong enough to be useful, weak enough to release the guest on demand.

Making and measuring the complexes

Cyclodextrins are manufactured enzymatically: liquefied starch is treated with cyclodextrin glucanotransferase (CGTase) from Bacillus species, which cleaves the amylose helix and rejoins the ends into rings. Product selectivity (α vs β vs γ) is steered by adding a "complexant" — e.g. toluene or decanol to precipitate β-CD as it forms.

Complexes themselves form under gentle conditions — no catalyst, no heat, no anhydrous solvent. Common laboratory methods include:

• Co-precipitation / stirring: dissolve host and guest in warm water (40–60 °C), cool, and the complex crystallizes.
• Kneading: a paste of cyclodextrin with a little water plus solid drug, ground until included — the standard industrial route.
• Freeze- or spray-drying of an aqueous solution to lock in an amorphous complex.

Stoichiometry and K_a are measured by phase-solubility analysis (Higuchi–Connors, 1965), isothermal titration calorimetry (ITC), and ¹H NMR — a diagnostic upfield shift of the cavity-lining H3 and H5 protons on the host confirms the guest is genuinely inside the pocket rather than merely surface-bound. NOESY cross-peaks between host-interior and guest protons give the binding geometry.

Scope, selectivity, and limitations

The defining feature of cyclodextrin chemistry is size- and shape-selective molecular recognition. A guest binds well only when its cross-section matches the cavity: nitrobenzene and adamantane are famously tight fits for β-CD (adamantane reaches K_a ≈ 10⁴–10⁵ M⁻¹), whereas a molecule too large is excluded and one too small rattles loosely with weak binding.

Because the host is chiral (built from D-glucose), cyclodextrins can even discriminate enantiomers: derivatized cyclodextrins bonded to silica are a workhorse chiral stationary phase in gas and liquid chromatography, and are added to the buffer in chiral capillary electrophoresis to separate drug enantiomers.

Limitations that shape real-world use:

• Native β-CD is only sparingly soluble (about 18.5 g/L) because of a rigid belt of intramolecular H-bonds around its rim; this is fixed by making derivatives such as hydroxypropyl-β-CD (HPβCD) and sulfobutylether-β-CD (SBEβCD, Captisol), which are soluble to hundreds of g/L and much safer to inject.
• Binding is typically 1:1 but 2:1 and 1:2 complexes occur for elongated or bulky guests.
• Complexes are dynamic and dissociate on dilution, on heating, or when a competitor displaces the guest — useful for controlled release, but it means the complex is never permanent.

Applications: drugs, foods, and materials

Cyclodextrins earn their industrial scale because a reversible pocket can hide a molecule's worst properties. In pharmaceuticals, encapsulating a poorly water-soluble drug can raise its apparent solubility by orders of magnitude and mask taste, odor, or chemical instability. Marketed examples include Sporanox (itraconazole in HPβCD), the antiviral Veklury (remdesivir formulated in SBEβCD/Captisol), piroxicam–β-CD tablets, and the anesthetic-reversal agent sugammadex — a modified γ-cyclodextrin that binds the muscle relaxant rocuronium with a remarkable K_a near 10⁷ M⁻¹, extracting it from the bloodstream in minutes.

• Food and flavor: β-CD stabilizes volatile flavors and vitamins, converts oils into free-flowing powders, and famously removes cholesterol from butter and eggs by complexing it. The consumer odor-eliminator Febreze works by trapping smelly molecules in cyclodextrin cavities.
• Cosmetics and textiles: cyclodextrins grafted onto fabrics slow-release fragrance; they also sequester UV filters and stabilize actives.
• Materials and catalysis: as chiral selectors in chromatography, as building blocks for rotaxanes and molecular machines (a cyclodextrin threaded on an axle), and as micro-reactors that pre-organize reactants to speed or steer reactions — a simple model for how enzymes bind substrates.

A brief history

The story begins in 1891, when Antoine Villiers digested starch with Bacillus amylobacter and isolated a crystalline substance he called "cellulosine." Between 1903 and 1911, Franz Schardinger identified two of the compounds (which for decades were called the Schardinger dextrins) and traced them to a bacterial enzyme.

Structural understanding matured in the 1930s–1950s: Karl Freudenberg and Friedrich Cramer established the cyclic, cone-shaped architecture and, crucially, showed in the 1950s that these rings form inclusion compounds — Cramer's work made cyclodextrins the founding molecules of what Jean-Marie Lehn would later name supramolecular chemistry (Nobel Prize, 1987, shared with Pedersen and Cram). Cheap enzymatic production from the 1970s onward turned a laboratory curiosity into a bulk commodity, and regulatory acceptance of HPβCD and SBEβCD in the 1990s–2000s cemented their role in modern drug formulation.

The three native cyclodextrins

Property	α-CD	β-CD	γ-CD
Glucose units	6	7	8
Cavity diameter (Å)	4.7–5.3	6.0–6.5	7.5–8.3
Water solubility (g/L, 25 °C)	145	18.5	232
Best guest size	small / linear chains	aromatic rings (benzene, phenyl)	large / steroids, fullerenes